References
- Coulter DA, Hugenard JR, Prince DA (1989): Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 25: 582–593.
- Litchfield ST, Wilcoxon FA (1949): A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–105.
- Macdonald RL, Kelly KM (1995): Antiepileptic drug mecha-nisms of action. Epilepsia 36(2): S2—S12.
- McCabe RT,Wasterlain CG, Kucharczyk N, Sofia RD, Vogel JR (1993): Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine- insensitive glycine receptors. J Pharmacol Exp Ther 264: 1248–1252.
- Rogawski MA, Porter RJ (1990): Antiepileptic drugs and phar-macological mechanisms and clinical efficacy with consid-eration of promising developmental stage compounds. Pharmacol Rev 42: 223–286.
- Subramaniam S, Rho JM, Penix L, Donevan SD, Fielding RP, Rogawski MA (1995): Felbamate block of the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther 273: 878–886.
- White HS (1997): New mechanisms of antiepileptic drugs. In: Epiepsies II, Boston, Butterworth Heinemann, pp. 1–30.
- Zargari A (1989): Medicinal Plants, Vol. II, Tehran, Tehran University Press, pp. 519–521.